Progressive loss of CD8+ T cell-mediated control of a γ-herpesvirus in the absence of CD4+ T cells

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 863-871

  Cardin, Rhonda D ^a   Brooks, James W ^a   Sarawar, Sally R ^a   Doherty, Peter C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY TEST; EXPERIMENTAL MODEL; FLOW CYTOMETRY; HELPER CELL; HERPES VIRUS INFECTION; KAPOSI SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 0029811734     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.863     Document Type: Article

References (49)

1. Moss, D.J., S.R. Burrows, R. Khanna, I.S. Misko, and T.B. Sculley. 1992. Immune surveillance against Epstein-Barr virus. Semin. Immunol. 4:97-104.
2. De Campos-Lima, P.O., V. Levitsky, J. Brooks, S.P. Lee, L.F. Hu, A.B. Rickinson, and M.G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179:1297-1305.
3. Borysiewicz, L.K., and J.G. Sissons. 1994. Cytotoxic T cells and human herpes virus infections. Curr. Top. Microbiol. Immunol. 189:123-150.
4. Yao, Q.Y., A.B. Rickinson, J.S. Gaston, and M.A. Epstein. 1985. In vitro analysis of the Epstein-Barr virus: host balance in longterm renal allograft recipients. Int. J. Cancer. 35:43-49.
5. Young, L., C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, K.C. Anderson, J. Ritz, R.S. Shapiro, A. Rickinson, E. Kieff, et al. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
6. Heslop, H.E., M.K. Brenner, and C. Rooney. 1994. Administration of neomycin resistance gene marked EBV specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum. Gene Ther. 5:381-397.
7. Walling, D.M., N.M. Clark, D.M. Markovitz, T.S. Frank, D.K. Braun, E. Eisenberg, D.J. Krutchkoff, D.H. Felix, and N. Raab-Traub. 1995. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J. Infect. Dis. 171:1122-1130.
8. Walling, D.M., and N. Raab-Traub. 1994. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J. Virol. 68:7909-7917.
9. Ganem, D. 1995. AIDS. Viruses, cytokines and Kaposi's sarcoma. Curr. Biol. 5:469-471.
10. Moore, P.S., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332:1181-1185.
11. Renne, R., W. Zhong, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med. 2:342-346.
12. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC), 262:1011-1018.
13. Cardin, RD., J.M. Boname, G.B. Abenes, S.A. Jennings, and E.S. Mocarski. 1993. Reactivation of murine CMV from latency. In Multidisciplinary Approaches to Understanding Cytomegalovirus Disease. S. Poltkin and S. Michelson, editors. Elsevier, Amsterdam, 101-110.
14. Doherty, P.C., R.A. Tripp, and J.W. Sixbey. 1994. Evasion of host immune responses by tumours and viruses. Ciba Found. Symp. 187:245-256.
15. Efstathiou, S., Y.M. Ho, and A.C. Minson. 1990. Cloning and molecular characterization of the murine herpesvirus 68 genome. J. Gen. Virol. 71:1355-1364.
16. Efstathiou, S., Y.M. Ho, S. Hall, C.J. Styles, S.D. Scott, and U.A. Gompels. 1990. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 71:1365-1372.
17. Sunil-Chandra, N.P., S. Efstathiou, J. Arno, and A.A. Nash. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73:2347-2356.
18. Sunil-Chandra, N.P., S. Efstathiou, and A.A. Nash. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:3275-3279.
19. Ehtisham, S., N.P. Sunil-Chandra, and A.A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:5247-5252.
20. + T cells. J. Gen. Virol. 77:627-630.
21. + T cells in major histocompatibility complex class II-deficient mice. Science (Wash. DC). 253:1417-1420.
22. Cardell, S., M. Merkenschlager, H. Bodmer, S. Chan, D. Cosgrove, C. Benoist, and D. Mathis. 1994. The immune system of mice lacking conventional MHC class II molecules. Adv. Immunol. 55:423-440.
23. Grusby, M.J., and L.H. Glimcher. 1995. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13: 417-435.
24. b gene. J. Immunol. 155:2955-2959.
25. + T cells. J. Immunol. 144:3980-3986.
26. + intraepithelial lymphocytes. Science (Wash. DC). 243: 1716-1718.
27. - gammaδ-T cells recovered from mice with influenza pneumonia. J. Immunol. 147:2069-2074.
28. + T cells. J. Immunol. 149:1319-1325.
29. + memory T cells. J. Immunol. 154:5870-5875.
30. + T cell depletion. Reg. Immunol. 5:142-150.
31. Sarawar, S.R., R.D. Cardin, J.W. Brooks, M. Mehrpooya, R.A. Tripp, and P.C. Doherty. 1996. Cytokine production in the immune response to murine gammaherpesvirus-68. J. Virol. 70:3264-3268.
32. Sarawar, S.R., and P.C. Doherty. 1994. Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J. Virol. 68:3112-3119.
33. Doherty, P.C., W. Allan, M. Eichelberger, and S.R. Carding. 1992. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
34. Moskophidis, D., F. Lechner, H. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (Lond.). 362:758-761.
35. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
36. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U.H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977-1984.
37. Jonjic, S., I. Pavic, B. Polic, I. Crnkovic, P. Lucin, and U.H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713-1717.
38. Polic, B., S. Jonjic, I. Pavic, I. Crnkovic, I. Zorica, H. Hengel, P. Lucin, and U.H. Koszinowski. 1996. Lack of MHC class 1 complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol. 77:217-225.
39. Jennings, S.R., R.H. Bonneau, P.M. Smith, R.M. Wolcott, and R. Chervenak. 1991. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell Immunol. 133: 234-252.
40. Bodmer, H., G. Obert, S. Chan, C. Benoist, and D. Mathis. 1993. Environmental modulation of the autonomy of cytotoxic T lymphocytes. Eur. J. Immunol. 23:1649-1654.
41. Laufer, T.M., M.G. Von Herrath, M.J. Grusby, M.B.A. Oldstone, and L.H. Glimcher. 1993. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. J. Exp. Med. 178:589-596.
42. Hou, S., X.Y. Mo, L. Hyland, and P.C. Doherty. 1995. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins. J. Virol. 69:1429-1434.
43. + T cells in respiratory virus infections. J. Immunol. 154:6013-6021.
44. + T cells in an in vivo response. J. Immunol. 155:3719-3721.
45. Fung-Leung, W.P., T.M. Kundig, R.M. Zinkernagel, and T.W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425-1429.
46. + T lymphocytes because of disruption of the beta 2-microglobulin gene. J. Virol. 67:332-339.
47. Masucci, M.G., and I. Ernberg. 1994. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol. 2:125-130.
48. Muller, D., B.H. Koller, J.L. Whitton, K.E. LaPan, K.K. Brigman, and J.A. Frelinger. 1992. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (Wash. DC). 255:1576-1578.
49. + T cells from mice with Sendai virus pneumonia. J. Virol. 67: 6299-6302.